PRIEST v. TEVA PHARMACEUTICALS USA INC et al
Consolidated
Lead case: 1:20-md-02974
Lead case: 1:20-md-02974
Georgia Northern District Court | |
Judge: | Leigh Martin May |
Case #: | 1:23-cv-01209 |
Nature of Suit | 365 Torts - Personal Injury - Product Liability |
Cause | 28:1332 Diversity-Personal Injury |
Case Filed: | Mar 22, 2023 |
Terminated: | Mar 23, 2023 |
Case in other court: | New Jersey, 2:23-cv-00416 |
Last checked: Monday Sep 18, 2023 6:47 AM EDT |
Defendant
Teva Women's Health LLC
|
|
Defendant
CooperSurgical, Inc.
|
|
Defendant
Teva Branded Pharmaceutical Products R&D, Inc.
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
Defendant
The Cooper Companies, Inc.
|
|
Plaintiff
ELAINE PRIEST
|
Represented By
|
TERMINATED PARTIES | |
Defendant
Teva Women's Health Inc
Terminated: 03/28/2023
|
Docket last updated: 01/26/2025 11:59 PM EST |
Friday, November 15, 2024 | ||
9 | 9
2
pgs
order
Order
Mon 11/18 7:48 PM
ORDER: Defendants' Consent Motion to Revise Leadership Structure for MDL Proceedings, Doc. No. 731, is GRANTED. Therefore, the Clerk is directed to substitute Kasey M. Adams, Esq., for Tara L. Blake, Esq., as Co-Lead Counsel for the Cooper Defendants in this action and in all associated cases. (Second Copy of 732 in 1:20-md-02974-LMM. Entered in member cases 1:22-cv-1028 through 3:20- cv-194.) Signed by Judge Leigh Martin May on 11/15/2024. (tht) |
|
8 | 8
1
pgs
order
Order
Mon 11/18 1:35 PM
ORDER granting (730 in 1:20-md-02974-LMM) Tara L. Blake's unopposed motion to withdraw as counsel of record for Defendants CooperSurgical, Inc. and The Cooper Companies, Inc. Signed by Judge Leigh Martin May on 11/15/2024. (Second Copy of 732 in 1:20-md-02974-LMM. Entered in member cases 1:22-cv-1028 through 3:20-cv-194.) (bgt) |
|
Wednesday, April 26, 2023 | ||
7 | 7
service
Waiver of Service Executed
Wed 04/26 8:35 AM
WAIVER OF SERVICE Returned Executed by ELAINE PRIEST. CooperSurgical, Inc. waiver mailed on 4/11/2023, answer due 6/12/2023; Teva Branded Pharmaceutical Products R&D, Inc. waiver mailed on 4/11/2023, answer due 6/12/2023; Teva Pharmaceuticals USA, Inc. waiver mailed on 4/11/2023, answer due 6/12/2023; Teva Women's Health LLC waiver mailed on 4/11/2023, answer due 6/12/2023; The Cooper Companies, Inc. waiver mailed on 4/11/2023, answer due 6/12/2023.(Galpern, Michael) |
|
Att: 1 Exhibit Waiver of Service of Summons for The Cooper Companies, | ||
Att: 2 Exhibit Waiver of Service of Summons for Cooper Surgical Inc., | ||
Att: 3 Exhibit Waiver of Service of Summons for Teva Women's Health,LLC., | ||
Att: 4 Exhibit Waiver of Service of Summons Teva Branded Pharmaceutical Products R&D, Inc., | ||
Att: 5 Exhibit Waiver of Service of Summons for Teva Pharmaceuticals USA, Inc. | ||
Tuesday, March 28, 2023 | ||
6 | 6
cmp
Amended Complaint
Tue 03/28 11:21 AM
First AMENDED COMPLAINT ELAINE PRIEST against Coopersurgical Inc, TEVA PHARMACEUTICAL R & D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health Inc, Teva Women's Health LLC, The Cooper Companies Incwith Jury Demand filed by ELAINE PRIEST.(Galpern, Michael) |
|
Att: 1 Civil Cover Sheet Civil Cover Sheet PRIEST | ||
Monday, March 27, 2023 | ||
utility
Remark
Mon 03/27 1:55 PM
Remark: Counsel should review all Orders docketed in MDL Case No. 1:20-md-2974-LMM. The Court's Case Management Orders and other case-related documents can also be found on the Court's MDL web page: https://www.gand.uscourts.gov/20md2974 (bnp) |
||
Thursday, March 23, 2023 | ||
5 | 5
6
pgs
order
Order
Thu 03/23 2:39 PM
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/21. (jra) |
|
utility
Terminate Civil Case
Thu 03/23 2:41 PM
Civil Case Terminated. (jra) |
||
Wednesday, March 22, 2023 | ||
4 | 4
transfer
Case Transferred In - District Transfer
Wed 03/22 3:21 PM
Case transferred in from District of New Jersey; Case Number 2:23-cv-00416. Original file certified copy of transfer order and docket sheet received. |
|
3 | 3
2
pgs
order
Order
Wed 03/22 1:09 PM
Order of MDL Panel transferring case to the Northern District of Georgia. (In Re: Paragard IUD Products Liability Litigation MDL 2974 CTO 55 - Judge Leigh Martin May) (gh, ) [Transferred from New Jersey on 3/22/2023.] |
|
Friday, January 27, 2023 | ||
2 | 2 SUMMONS ISSUED as to COOPERSURGICAL, INC., TEVA PHARMACEUTICAL R & D, INC., TEVA PHARMACEUTICALS USA INC, TEVA WOMEN'S HEALTH INC., TEVA WOMEN'S HEALTH, LLC, THE COOPER COMPANIES INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (qa, ) [Transferred from New Jersey on 3/22/2023.] | |
Wednesday, January 25, 2023 | ||
1 | 1 COMPLAINT against COOPERSURGICAL, INC., TEVA PHARMACEUTICAL R & D, INC., TEVA PHARMACEUTICALS USA INC, TEVA WOMEN'S HEALTH, INC. d/b/a TEVA WOMEN'S HEALTH, LLC, TEVA WOMEN'S HEALTH, LLC, THE COOPER COMPANIES INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13983558) with JURY DEMAND, filed by ELAINE PRIEST.(GALPERN, MICHAEL) [Transferred from New Jersey on 3/22/2023.] | |
Att: 1 Civil Cover Sheet | ||
Case Assigned to Judge Evelyn Padin and Magistrate Judge Edward S. Kiel. (ak, ) [Transferred from New Jersey on 3/22/2023.] |